Sort
51,593 grants matching “hepatitis”
Gulf Longitudinal Follow-up (GuLF) Study
$1,320,053Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2019 · ES
Characterization of human hematopoietic and endodermal progenitors derived from i
$1,319,537Darrell N. Kotton · Boston University Medical Campus · RC2 · FY2010 · HL
UCSF HIV Clinical Trials Unit
$1,319,536Diane V Havlir · University Of California, San Francisco · U01 · FY2010 · AI
Investigation of management and disease manifestations of viral hepatitis
$1,319,082Theo Heller · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Study of Viral Resistance to Antiviral Therapy of Chron*
$1,318,252University Of Pittsburgh At Pittsburgh · U01 · FY2001 · DK
Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases
$1,317,817Chi-Chao Chan · National Eye Institute · Z01 · FY2008 · EY
Cherokee Nation Native AmericanResearch Center for Health
$1,317,488Sohail Imran Khan · Cherokee Nation · S06 · FY2022 · GM
SIGNALING PATHWAYS IN CONTROL OF GROWTH AND DEVELOPMENT
$1,317,221Alan R Kimmel · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK
Metabolic Studies of Mouse Models of Obesity and Diabetes
$1,316,975Oksana Gavrilova · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2021 · DK
Structural Biology Of Virus Assembly
$1,316,863Alasdair C. Steven · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2017 · AR
Center for Interventional Oncology
$1,316,258Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2021 · CA
Stellenbosch University Clinical Trials Unit
$1,315,748Anneke Catharina Hesseling · Stellenbosch University · UM1 · FY2024 · AI
Philadelphia HIV Therapeutics and Prevention Clinical Trials Unit
$1,315,740Pablo Tebas · University Of Pennsylvania · UM1 · FY2015 · AI
TIM recognition of phosphatidylserine regulates innate and adaptive immunity
$1,313,791Dale T Umetsu · Boston Children'S Hospital · P01 · FY2010 · AI
Pathogenesis and Novel Therapeutic Targets of Fatty Liver Disease and Cancer
$1,313,141Bin Gao · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2022 · AA
Molecular mechanisms of liver injury, repair, and immunity
$1,313,140Bin Gao · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2022 · AA
Virology Core
$1,313,048Julie A Nelson · Univ Of North Carolina Chapel Hill · P30 · FY2012 · AI
Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid Receptors
$1,311,436Kenner Rice · National Institute On Drug Abuse · ZIA · FY2015 · DA
Epidemiologic Study of Hepatocellular Carcinoma in the US
$1,310,686Herbert Yu · Yale University · R01 · FY2010 · CA
Nox family NADPH oxidases: roles in innate immunity and inflammatory disease
$1,308,673Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Studies of Rare Cancers
$1,307,370Katherine McGlynn · Division Of Cancer Epidemiology And Genetics · ZIA · FY2024 · CA
Integrated Epithelial and Mucosal Biology
$1,307,347Wayne Lencer · Boston Children'S Hospital · P30 · FY2017 · DK
Northwest Reference Epigenome Mapping Center
$1,306,200John A Stamatoyannopoulos · University Of Washington · U01 · FY2011 · ES
Natural History of HIV Infection in Injection Drug Users
$1,306,165Johns Hopkins University · R37 · FY2004 · DA
Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease
$1,304,892Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI